Palbociclib Regimen Yields 'Incredible' PFS Gain in Metastatic Breast Cancer

(MedPage Today) -- SAN ANTONIO -- The addition of palbociclib (Ibrance) to current standard-of-care therapy following induction chemotherapy resulted in a significant and clinically meaningful improvement in progression-free survival (PFS) in...